Outlook Therapeutics
OTLK
#8491
Rank
HK$1.01 B
Marketcap
HK$42.87
Share price
-7.55%
Change (1 day)
-37.61%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -HK$0.74 Billion

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$0.41 Billion, an increase over its 2022 earnings that were of -HK$0.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.74 Billion83.87%
2023 -HK$0.41 Billion-26.7%
2022 -HK$0.55 Billion32.13%
2021 -HK$0.42 Billion46.21%
2020 -HK$0.29 Billion-18.82%
2019 -HK$0.35 Billion16.62%
2018 -HK$0.3 Billion57.88%
2017 -HK$0.19 Billion-56.17%
2016 -HK$0.44 Billion-9.26%
2015 -HK$0.48 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.9 Billion 21.71% Jersey
-HK$2.13 Billion 190.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.11 Billion-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.57 Billion-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK